NK Biocell

NK Biocell is a South Korean biotechnology company specializing in the development of next-generation immune cell therapies, specifically focusing on Natural Killer (NK) cells. The company utilizes a proprietary platform for the high-purity expansion and activation of autologous NK cells to treat various forms of cancer, including solid tumors. Beyond therapeutic development, NK Biocell provides immune cell banking services, allowing individuals to store healthy immune cells for future medical use. Their research aims to overcome the limitations of current cancer treatments by enhancing the body's natural immune response through highly potent, non-genetically modified NK cell products. The company is currently advancing its pipeline through clinical research in South Korea, targeting indications such as lung and liver cancer.